According to Epizyme's latest financial reports the company's current earnings (TTM) are -$0.19 B. .
Year | Earnings | Change |
---|
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.82 B | -5,452.57% | ๐จ๐ญ Switzerland |
Abbott Laboratories ABT | $6.66 B | -3,729.75% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | -4,204.18% | ๐ฌ๐ง UK |
Seagen
SGEN | -$0.8 B | 330.61% | ๐บ๐ธ USA |